US FDA says malaria drugs in shortage as coronavirus drives up demand
AMERİCA

US FDA says malaria drugs in shortage as coronavirus drives up demand

News Service Reuters

The U.S. Food and Drug Administration said malaria drugs hydroxychloroquine and related chloroquine are in shortage due to a surge in demand because of the coronavirus pandemic.

The drugs, which have been tried with some success to treat the illness caused by the virus, were added to the agency's website that lists drug shortages on Tuesday.

+

We use cookies limited for the aims specified in the data policy and in accordance with the legislation. For details please see our data policy.